Literature DB >> 11750731

46,XX sex reversal.

J C Zenteno-Ruiz1, S Kofman-Alfaro, J P Méndez.   

Abstract

In humans, sexual differentiation is directed by SRY, a master regulatory gene located at the Y chromosome. This gene initiates the male pathway or represses the female pathway by regulating the transcription of downstream genes; however, the precise mechanisms by which SRY acts are largely unknown. Moreover, several genes have recently been implicated in the development of the bipotential gonad even before SRY is expressed. In some individuals, the normal process of sexual differentiation is altered and a sex reversal disorder is observed. These subjects present the chromosomes of one sex but the physical attributes of the other. Over the past years, considerable progress has been achieved in the molecular characterization of these disorders by using a combination of strategies including cell biology, animal models, and by studying patients with these pathologic entities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11750731     DOI: 10.1016/s0188-4409(01)00322-8

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  12 in total

1.  Clinical and molecular studies in four patients with SRY-positive 46,XX testicular disorders of sex development: implications for variable sex development and genomic rearrangements.

Authors:  Shinichi Nakashima; Akira Ohishi; Fumio Takada; Hideki Kawamura; Maki Igarashi; Maki Fukami; Tsutomu Ogata
Journal:  J Hum Genet       Date:  2014-08-07       Impact factor: 3.172

2.  Sex chromosome aneuploidies among men with systemic lupus erythematosus.

Authors:  Skyler P Dillon; Biji T Kurien; Shibo Li; Gail R Bruner; Kenneth M Kaufman; John B Harley; Patrick M Gaffney; Daniel J Wallace; Michael H Weisman; R Hal Scofield
Journal:  J Autoimmun       Date:  2011-12-06       Impact factor: 7.094

3.  Y Chromosome Genes May Play Roles in the Development of Neural Rosettes from Human Embryonic Stem Cells.

Authors:  Farzaneh Khani; Simin Nafian; Sepideh Mollamohammadi; Shiva Nemati; Bahare Shokoohian; Seyedeh Nafiseh Hassani; Hossein Baharvand; Hamid Reza Soleimanpour-Lichaei; Ghasem Hosseini Salekdeh
Journal:  Stem Cell Rev Rep       Date:  2022-06-03       Impact factor: 5.739

Review 4.  Sex Assignment in Conditions Affecting Sex Development.

Authors:  Renata Markosyan; S Faisal Ahmed
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-12-27

5.  Ten cases with 46,XX testicular disorder of sex development: single center experience.

Authors:  Emre Can Akinsal; Numan Baydilli; Abdullah Demirtas; Cetin Saatci; Oguz Ekmekcioglu
Journal:  Int Braz J Urol       Date:  2017 Jul-Aug       Impact factor: 1.541

6.  Patient with Disorders of Sex Development (DSD): A Case Report from a Tertiary Care Hospital in Thiruvananthapuram, India.

Authors:  Pongillyathundiyil Sasidharan Sreejith; Sheila Balakrishnan; Vaikom Hariharan Sankar; Remya Syamala; Reji Mohan; Sankar Sundaram; Krishna Govindan; Kaleeluvilayil Raghavan Nair Chandramohanan Nair
Journal:  J Reprod Infertil       Date:  2019 Jul-Sep

7.  46,XX male disorder of sexual development:a case report.

Authors:  Ahmet Anık; Gönül Çatlı; Ayhan Abacı; Ece Böber
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013

8.  A newborn with ambiguous genitalia and a complex X;Y rearrangement.

Authors:  Mohammadreza Dehghani; Elena Rossi; Annalisa Vetro; Gianni Russo; Zahra Hashemian; Orsetta Zuffardi
Journal:  Iran J Reprod Med       Date:  2014-05

9.  Clinical, molecular and cytogenetic analysis of 46, XX testicular disorder of sex development with SRY-positive.

Authors:  Qiu-Yue Wu; Na Li; Wei-Wei Li; Tian-Fu Li; Cui Zhang; Ying-Xia Cui; Xin-Yi Xia; Jin-Sheng Zhai
Journal:  BMC Urol       Date:  2014-08-28       Impact factor: 2.264

10.  The Occurrence of 275 Rare Diseases and 47 Rare Disease Groups in Italy. Results from the National Registry of Rare Diseases.

Authors:  Domenica Taruscio; Luciano Vittozzi; Adele Rocchetti; Paola Torreri; Luca Ferrari
Journal:  Int J Environ Res Public Health       Date:  2018-07-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.